John D. Mitchell
University of Colorado Anschutz · 180 works · 7,225 citations · h-index 38
Top works
- Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial
- Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
- Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections
- Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
- The Society of Thoracic Surgeons Clinical Practice Guidelines on Arterial Conduits for Coronary Artery Bypass Grafting
- Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)
- Thoracoscopic Lobectomy Has Increasing Benefit in Patients With Poor Pulmonary Function
- Clinical experience with carinal resection
- Resection for bronchogenic carcinoma involving the carina: Long-term results and effect of nodal status on outcome
- Fewer complications result from a video-assisted approach to anatomic resection of clinical stage I lung cancer
- Expert Consensus Document on Pulmonary Metastasectomy
- An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non–Small Cell Lung Cancers
- The Society of Thoracic Surgeons Expert Consensus for the Resuscitation of Patients Who Arrest After Cardiac Surgery
- Management of Alveolar Air Leaks After Pulmonary Resection
- Three-dimensional keconstruction of ventricular septal defects: Validation studies and in vivo feasibility
- Non-invasive Breath Analysis of Pulmonary Nodules
- Anatomic Lung Resection for Nontuberculous Mycobacterial Disease
- Oligoclonal CD4+ T Cells in the Lungs of Patients with Severe Emphysema
- Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non–Small Cell Lung Cancer Patients
- Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non–Small-Cell Lung Cancer